Amgen Market Cap

Amgen has a market cap or net worth of $182.32 billion as of February 4, 2026. Its market cap has increased by 24.65% in one year.

Market Cap

182.32B

Enterprise Value

227.80B

1-Year Change

24.65%

Ranking

#76

Market Cap Chart

Since December 1, 1998, Amgen's market cap has increased from $19.50B to $182.32B, an increase of 834.87%. That is a compound annual growth rate of 8.57%.

Market Cap History

Date	Market Cap	% Change
Feb 3, 2026	182.32B	3.45%
Dec 31, 2025	176.25B	25.80%
Dec 31, 2024	140.10B	-9.11%
Dec 29, 2023	154.14B	9.99%
Dec 30, 2022	140.14B	10.59%
Dec 31, 2021	126.72B	-5.33%
Dec 31, 2020	133.85B	-6.55%
Dec 31, 2019	143.24B	15.47%
Dec 31, 2018	124.05B	-1.73%
Dec 29, 2017	126.24B	16.06%
Dec 30, 2016	108.77B	-11.17%
Dec 31, 2015	122.45B	1.06%
Dec 31, 2014	121.17B	40.84%
Dec 31, 2013	86.03B	30.06%
Dec 31, 2012	66.15B	17.52%
Dec 30, 2011	56.28B	8.51%
Dec 31, 2010	51.87B	-9.41%
Dec 31, 2009	57.26B	-6.42%
Dec 31, 2008	61.19B	21.14%
Dec 31, 2007	50.51B	-36.61%
Dec 29, 2006	79.68B	-18.14%
Dec 30, 2005	97.34B	19.46%
Dec 31, 2004	81.48B	2.22%
Dec 31, 2003	79.71B	28.11%
Dec 31, 2002	62.22B	5.44%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Johnson & Johnson	561.61B
AbbVie	398.83B
AstraZeneca	293.45B
Novartis AG	289.31B
Merck & Co.	287.52B
Novo Nordisk	258.46B
Gilead Sciences	177.76B
Pfizer	146.52B

Market Cap Rankings